1. Sharma A, et al., “S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician Oriented Review of Research.” J Clinic Psychiatry Jun 2017 [Internet] PMID28682528 [cited 2020 Nov 23]
2. Cui Y, Zheng Y, “A meta-analysis on the efficacy and safety of St John’s Wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults.” Neuropsychiatr Dis Treat. 2016 [Internet] PMID 27468236 [cited 2020 Nov 23]
3. Editor NDNR, “Toxicity and Depression“, Naturopathic Doctor News and Review 2012 Mar 23 [Internet] [cited 2020 Nov 23]
4. Craft L, Perna F, “The Benefits of Exercise for the Clinically Depressed’ Prim Care Companion J Clin Psychiatry 2004 [Internet] PMID15361924 [cited 2020 Dec 22]
5. Kent S, et al., “Effect of sunlight exposure on cognitive function among depressed and non-depressed participants: a REGARDS cross-sectional study.” Environ Health 2009 July 09 [Internet] PMID 19638105 [cited 2020 Nov 23]
18.The drugs don’t work? antidepressants and the current and future pharmacological management of depression Ther Adv Psychopharmacol. 2012 Oct; 2(5): 179–188. Elizabeth Penncor responding author and Derek K. Tracy [cited 2020, Dec 19]
7. Antidepressant Discontinuation Syndrome, Am Fam Physician. 2006 Aug 1;74(3):449-456. [cited 2020 Dec 19]
15.How does cocaine produce its effects?. NIDA. 2020, June 11. [cited 2020, Dec19]
16.Serotonin: What You Need to Know Healthline Written by Annamarya Scaccia — Updated on August 19, 2020 [cited 2020, December 19]
17. Stahl SM, Grady MM, Moret C, Briley M. “SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.” CNS Spectr. 2005 Sep;10(9):732-47. doi: 10.1017/s1092852900019726. PMID: 16142213. [cited 2020 Dec 22]
20. FDA label Cymbalta (duloxetine) {2008 Dec 4] [cited 2020 Dec 22]
21. Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., Atkins, D. C., Dunner, D. L., & Jacobson, N. S. (2006). “Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.” Journal of Consulting and Clinical Psychology, 74(4), 658–670. https://doi.org/10.1037/0022-006X.74.4.658 [cited 2020 Dec 23]
22. Adjibade, M., Julia, C., Allès, B., Touvier, M., Lemogne, C., Srour, B., … & Kesse-Guyot, E. (2019). “Prospective association between ultra-processed food consumption and incident depressive symptoms in the French NutriNet-Santé cohort.” BMC medicine, 17(1), 78. [cited 2020 Dec 23]
23. Bell IR, Jasnoski ML, Kagan J, King DS. “Depression and allergies: survey of a nonclinical population.” Psychother Psychosom. 1991;55(1):24-31. doi: 10.1159/000288404. PMID: 1866437. [cited 2020 Dec 23]
24. Bahls SC, de Carvalho GA. “A relação entre a função tireoidiana e a depressão: uma revisão [The relation between thyroid function and depression: a review].” Braz J Psychiatry. 2004 Mar;26(1):41-9. Portuguese. doi: 10.1590/s1516-44462004000100012. Epub 2004 Mar 30. PMID: 15057840. [cited 2020 Dec 23]
25. Fu Z, Xi S. “The effects of heavy metals on human metabolism.” Toxicol Mech Methods. 2020 Mar;30(3):167-176. doi: 10.1080/15376516.2019.1701594. Epub 2019 Dec 17. PMID: 31818169. [cited 2020 Dec 23]
26. Cowen P, Browning M, “What has serotonin to do with depression?” Journal World Psychiatry 2015 June, 14(2): 158-160 [online] PMID 26043325 [cited 2020 Dec 23]
27. Lacasse J, Leo J, “Serotonin and Depression: A Disconnect Between the Advertisements and the Scientific Literature.” PLos Med 2005 Dec [online] PMID 16268734 [cited 2020 Dec 23]
28. Seisser W et al., “Chronic SSRI Treatment Exacerbates Serotonin Deficiency in Humanized Tph2 Mutant Mice.” ACS Chem Neurosci. 2013 Jan 16: 4(1): 84-88 [online] PMID 23336047 [cited 2020 Dec 23]
29. Cowen PJ. “Serotonin and depression: pathophysiological mechanism or marketing myth?” Trends Pharmacol Sci. 2008 Sep;29(9):433-6. doi: 10.1016/j.tips.2008.05.004. PMID: 18585794. [cited 2020 Dec 23]
30. McGill Information Presentation, ‘The Brain from Top to Bottom – Serotonin and other molecules involved in depression.” [online] N.D. [cited 2020 Dec 23]
31. Di Chiara G, Bassareo V. “Reward system and addiction: what dopamine does and doesn’t do.” Curr Opin Pharmacol. 2007 Feb;7(1):69-76. doi: 10.1016/j.coph.2006.11.003. Epub 2006 Dec 15. Erratum in: Curr Opin Pharmacol. 2007 Apr;7(2):233. PMID: 17174602. [cited 2020 Dec 23]
32. Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, Mertens P, Benabid AL, Pollak P, Broussolle E. “Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.” Arch Neurol. 2004 Nov;61(11):1705-9. doi: 10.1001/archneur.61.11.1705. PMID: 15534182.[cited 2020 Dec 23]
33. Taylor C, et al., “Mechanisms of action of antidepressants: from neurotransmitter systems to signalling pathways.” Cell Signal PMID 15683730 [cited 2020 Dec 23]
34. Fava GA. “Can long-term treatment with antidepressant drugs worsen the course of depression?” J Clin Psychiatry. 2003 Feb;64(2):123-33. doi: 10.4088/jcp.v64n0204. PMID: 12633120. [cited 2020 Dec 23]
35. Smith B, “Inappropriate Prescribing.” American Psychological Association publication [online] June 2012 [cited 2020 Dec 23]
36. Berger M, et al., “The Expanded Biology of Serotonin” Annual Review of Medicine [online[ Feb 2009 PMID 19630576 [cited 2020 Dec 23[
37. Dmitrzak-Weglarz M, Reszka E. “Pathophysiology of Depression: Molecular Regulation of Melatonin Homeostasis – Current Status.” Neuropsychobiology. 2017;76(3):117-129. doi: 10.1159/000489470. Epub 2018 Jun 13. PMID: 29898451.[cited 2020 Dec 23]